MANGALAM GLOBAL ENTERPRISE
Back to Balance Sheet
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹333 Cr | ₹241 Cr | ₹290 Cr | ₹167 Cr | ₹138 Cr |
What is the latest Total Current Liabilities ratio of MANGALAM GLOBAL ENTERPRISE ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹333 Cr |
Mar2024 | ₹241 Cr |
Mar2023 | ₹290 Cr |
Mar2022 | ₹167 Cr |
Mar2021 | ₹138 Cr |
How is Total Current Liabilities of MANGALAM GLOBAL ENTERPRISE Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹333 Cr | 38.03 | |
Mar2024 | ₹241 Cr | -16.89 | |
Mar2023 | ₹290 Cr | 74.27 | |
Mar2022 | ₹167 Cr | 20.76 | |
Mar2021 | ₹138 Cr | - |
Compare Total Current Liabilities of peers of MANGALAM GLOBAL ENTERPRISE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANGALAM GLOBAL ENTERPRISE | ₹569.5 Cr | 0.7% | 13.1% | NA | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹13,267.8 Cr | -0.8% | -3.8% | -16.9% | Stock Analytics | |
KAVERI SEED COMPANY | ₹5,584.5 Cr | -2% | -8.8% | 3.9% | Stock Analytics | |
VENKYS (INDIA) | ₹2,119.4 Cr | -1.5% | -6.5% | -23.7% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,421.2 Cr | 1.2% | -3.8% | -31.6% | Stock Analytics | |
INDO US BIOTECH | ₹339.7 Cr | 5.8% | 11.2% | -20.5% | Stock Analytics |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANGALAM GLOBAL ENTERPRISE | 0.7% |
13.1% |
|
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses